Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07039175 · ClinicalTrials.gov registry record · Phase 3
Intervention to Increase Intention to Change Alcohol/Tobacco Use in Veterans With Chronic Disease
A Phase 3 study of Tobacco Smoking and Alcohol-Related Disorders, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT07039175: Recruiting Phase 3 study of Tobacco Smoking and Alcohol-Related Disorders, sponsored by VA Office of Research and Development.
NCT07039175 is a Phase 3 study of Tobacco Smoking and Alcohol-Related Disorders that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 270 participants, below the 470-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07039175, a Phase 3 study of Tobacco Smoking and Alcohol-Related Disorders, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
Many Veterans who have chronic conditions like cardiovascular disease or diabetes smoke or drink too much alcohol, which can worsen the condition. Veterans are asked yearly about drinking/smoking and providers provide a brief advice discussion focused on behavior change. However, many Veterans continue to drink or smoke, and are often not interested in higher-intensity, change-based referrals. The investigators recently piloted MINDSET, an intervention that fills this gap. MINDSET is a proactive, population-based intervention that uses a mailed packet with tailored education about how drinking/smoking relate to the Veteran's condition (heart conditions and/or diabetes), followed by a brief motivational call. The investigators will test MINDSET's effectiveness versus usual primary care on outcomes including intention to change and substance use and evaluate the relationships between these and other variables over time.
Primary Outcome
3 items regarding intention to change measured on a 7-point Likert-type scale from (1) very unlikely to (7) very likely.
Conditions Studied
Interventions
- OTHER Usual Care
- BEHAVIORAL MINDSET
Study Locations (1)
New York
- VA Western New York Healthcare System, Buffalo, NY - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2029-06-30 |
| Phase | Phase 3 |
What NCT07039175 shows while recruiting
NCT07039175 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, below the 470-participant average among 38 other Tobacco Smoking trials with a reported enrollment target (43% lower).
The record links to 2 conditions, with Tobacco Smoking appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT07039175 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07039175 about?
NCT07039175 is a clinical study titled "Intervention to Increase Intention to Change Alcohol/Tobacco Use in Veterans With Chronic Disease". Many Veterans who have chronic conditions like cardiovascular disease or diabetes smoke or drink too much alcohol, which can worsen the condition. Veterans are asked yearly about drinking/smoking and providers provide a brief advice discussion focused on behavior change. However, many Veterans conti...
What is the current status of trial NCT07039175?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 270 participants. The study started on 2025-10-01. Estimated completion is 2029-06-30.
What conditions does trial NCT07039175 study?
This clinical trial studies the following conditions: Tobacco Smoking, Alcohol-Related Disorders.
What interventions are being tested in trial NCT07039175?
The interventions under investigation include: Usual Care (OTHER), MINDSET (BEHAVIORAL).
Who is sponsoring clinical trial NCT07039175?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07039175 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07039175's enrollment target sits among peer trials
270 8th of 38 higher than 31 of 38 other Tobacco Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Cannabidiol on Stress and Nicotine Withdrawal
RECRUITING · Phase 1
-
Cannabidiol for Reducing Cigarette Use
RECRUITING · Phase 2
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
RECRUITING
-
Development of a Smoking Cessation Video Series
RECRUITING · NA
-
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI